Recombinant TNFRSF8 (Brentuximab Biosimilar) antibody

Catalog No. ABIN6964430

Product Details anti-TNFRSF8 (Brentuximab Biosimilar) Antibody

Target: TNFRSF8 (Brentuximab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Mouse

Clonality: Chimeric

Conjugate: This TNFRSF8 (Brentuximab Biosimilar) antibody is un-conjugated

Application: ELISA

Purpose: Anti-CD30 (brentuximab biosimilar) mAb

Characteristics: Common Name: SGN-35, cAC10-Val-Cit-MMAE

Purification: Purified from cell culture supernatant by affinity chromatography

Grade: Research Grade

Isotype: IgG1

Application Details

Application Notes: ELISA 1:5000-10000

Comment:

Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.

Restrictions: For Research Use only

Handling

Format: Lyophilized

Reconstitution: Reconstitute with deionized water

Buffer: 50 % Glycerol, PBS, pH 7.4, 0.1 % BSA, 0.1 % Procline 300

Preservative: ProClin

Precaution of Use: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Storage: -20 °C,-80 °C

Storage Comment: Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing).Lyophilized proteins are shipped at ambient temperature.

Expiry Date: 12 months

Target Details for TNFRSF8 (Brentuximab Biosimilar)

Target: TNFRSF8 (Brentuximab Biosimilar)

Alternative Name: CD30 (Brentuximab Biosimilar) (TNFRSF8 (Brentuximab Biosimilar) Products)

Target Type: Biosimilar

Background: Synonyms: TNFRSF8,CD30,D1S166E,Ki-1